| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/06/2013 | CN101936986B Method for detecting diazepam and chemoluminescence immunoassay kit special for same |
| 03/06/2013 | CN101724069B Preparation method of yolk antibody IgY of high-abundance protein in anti-human serum/blood plasma and application thereof |
| 03/06/2013 | CN101676726B Preparation method of E hepatitis rabbit-human chimeric antibody quality control substance |
| 03/06/2013 | CN101160526B Antibody directed against gastrin-releasing peptide precursor and use thereof |
| 03/05/2013 | US8389694 Biologically active antibodies recognizing a cell surface molecule selectively expressed on living mouse natural type one (I) interferon producing cells |
| 03/05/2013 | US8389690 Antibodies to JTT-1 protein and cells secreting such antibodies |
| 03/05/2013 | US8389689 Anti-GLP-1R antibodies and their uses |
| 03/05/2013 | US8389688 Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
| 03/05/2013 | US8389481 Glutamate-enhanced cell-penetrating peptides and methods of using same |
| 03/05/2013 | US8389477 Amylin and amylin agonists for treating psychiatric diseases and disorders |
| 03/05/2013 | US8389242 Process for producing Apo2L |
| 03/05/2013 | US8389227 Method for diagnosing cancers expressing the HER2 receptor or its truncated variants |
| 03/05/2013 | US8389016 Use of a CD28 binding substance for making a pharmaceutical composition |
| 03/05/2013 | US8388975 Cancer antigen peptides derived from WT1 |
| 03/05/2013 | US8388974 Neovascular-targeted immunoconjugates |
| 03/05/2013 | US8388973 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 03/05/2013 | US8388972 Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ovarian carcinoma |
| 03/05/2013 | US8388971 Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses |
| 03/05/2013 | US8388969 Interleukin-1 alpha antibodies and methods of use |
| 03/05/2013 | US8388968 Compositions and methods for increasing muscle growth |
| 03/05/2013 | US8388966 Combination treatment of pancreatic cancer |
| 03/05/2013 | US8388965 Antibodies that bind IL-4 and/or IL-13 and their uses |
| 03/05/2013 | US8388962 Molecules and methods of using same for treating MCP-1/CCR2 associated diseases |
| 03/05/2013 | US8388956 Interleukin-1 alpha antibodies and methods of use |
| 03/05/2013 | US8388955 Fc variants |
| 03/05/2013 | US8388933 Multimeric protein toxins to target cells having multiple identifying characteristics |
| 03/05/2013 | CA2595610C Antibodies directed to angiopoietin-2 and uses thereof |
| 03/05/2013 | CA2570050C Heart and skeletal muscle inflammation (hsmi) virus |
| 02/28/2013 | WO2013028810A1 Clostridium difficile antibodies |
| 02/28/2013 | WO2013028442A1 Anti-tie2 antibodies uses thereof |
| 02/28/2013 | WO2013028330A2 Methods of reducing level of one of more impurities in a sample during protein purification |
| 02/28/2013 | WO2013028231A1 Anti-ox40 antibodies and methods of using the same |
| 02/28/2013 | WO2013028137A1 A protein involved in detection of cancer metastasis and a treatment thereof |
| 02/28/2013 | WO2013027802A1 Novel anti-ddr1 antibody having anti-tumor activity |
| 02/28/2013 | WO2013027356A1 Antibody and antibody-containing composition |
| 02/28/2013 | WO2013026878A1 Anti-vcam-1 nanobodies |
| 02/28/2013 | WO2013026839A1 Bispecific antibodies specific for t-cell activating antigens and a tumor antigen and methods of use |
| 02/28/2013 | WO2013026837A1 Bispecific t cell activating antigen binding molecules |
| 02/28/2013 | WO2013026835A1 Fc-free antibodies comprising two fab fragments and methods of use |
| 02/28/2013 | WO2013026833A1 Bispecific t cell activating antigen binding molecules |
| 02/28/2013 | WO2013026832A1 Anti-mcsp antibodies |
| 02/28/2013 | WO2013026831A1 Bispecific antigen binding molecules |
| 02/28/2013 | WO2013026452A1 Method for removing immunosuppresive properties of hiv envelope glycoproteins |
| 02/28/2013 | WO2013026099A1 Fn14 binding proteins and uses thereof |
| 02/28/2013 | WO2013003680A8 Anti-c-met antibody formulations |
| 02/28/2013 | WO2012177695A3 Hybrid polymerases having the ability to produce long amplicons |
| 02/28/2013 | WO2012158195A3 Toxin and pathogen clearance |
| 02/28/2013 | WO2012151248A3 FORMULATION FOR ANTI-α4β7 ANTIBODY |
| 02/28/2013 | WO2012104014A9 A method for the production of hybridoma cell lines producing monoclonal antibodies capable to specifically binding to a human c44-fragment of agrin |
| 02/28/2013 | WO2007025388A9 Anti-apoptotic protein antibodies |
| 02/28/2013 | US20130053549 Multivalent Antibodies |
| 02/28/2013 | US20130053547 Agonist antibody to human thrombopoietin receptor |
| 02/28/2013 | US20130053428 Natural antisense and non-coding rna transcripts as drug targets |
| 02/28/2013 | US20130053271 Self-Assembled Bead-Based Multiplexed Assay For Antigen-Specific Antibodies |
| 02/28/2013 | US20130052666 Antibody against human tsh and canine tsh |
| 02/28/2013 | US20130052654 Amyloid Precursor Protein E2 Domain and Uses Thereof |
| 02/28/2013 | US20130052634 Hcv genotype 4 replicons |
| 02/28/2013 | US20130052633 Hcv genotype 3 replicons |
| 02/28/2013 | US20130052209 Protein drug formulations and packages |
| 02/28/2013 | US20130052207 Prognostic Method for Pulmonary Adenocarcinoma, Pulmonary Adenocarcinoma Detection Kit, and Pharmaceutical Composition for Treating Pulmonary Adenocarcinoma |
| 02/28/2013 | US20130052205 Flt3 receptor antagonists for the treatment or the prevention of pain disorders |
| 02/28/2013 | US20130052203 In vivo screening models for treatment of qc-related disorders |
| 02/28/2013 | US20130052202 HIGH AFFINITY, ANTI-HUMAN IgE ANTIBODIES |
| 02/28/2013 | US20130052200 Naturally occurring autoantibodies against alpha-synuclein that inhibit the aggregation and cytotoxicity of alpha-synuclein |
| 02/28/2013 | US20130052197 Novel anti-cd98 antibody and use thereof |
| 02/28/2013 | US20130052194 Anti-prostate cancer antibodies and methods of detection and treatment of prostate cancer using the same |
| 02/28/2013 | US20130052191 Anti-alpha2 integrin antibodies and their uses |
| 02/28/2013 | US20130052187 Antibodies Directed Against Hepatitis C Virus E1E2 Complex, Compositions of HCV Particles, and Pharmaceutical Compositions |
| 02/28/2013 | US20130052163 Human Rhinovirus (HRV) Antibodies |
| 02/28/2013 | US20130052135 Molecules With Extended Half-Lives, Compositions And Uses Thereof |
| 02/28/2013 | US20130052130 Branched Discreet PEG Constructs |
| 02/28/2013 | US20130052128 Upar Binding Agents and Methods of Use Thereof |
| 02/28/2013 | DE102010039018B4 Anti-La Antikörper und ihre Anwendung zum Immunotargeting Anti-La antibodies and their application to Immunotargeting |
| 02/28/2013 | CA2846494A1 Compounds for use in boosting coagulation |
| 02/28/2013 | CA2846251A1 Anti-vcam-1 nanobodies |
| 02/28/2013 | CA2846197A1 Novel kif5b-ret fusion molecules and uses thereof |
| 02/28/2013 | CA2845946A1 Fn14-binding proteins and uses thereof |
| 02/28/2013 | CA2845884A1 Clostridium difficile antibodies |
| 02/28/2013 | CA2845810A1 Anti-ox40 antibodies and methods of using the same |
| 02/28/2013 | CA2844540A1 Bispecific antibodies specific for t-cell activating antigens and a tumor antigen and methods of use |
| 02/28/2013 | CA2844538A1 Bispecific antigen binding molecules |
| 02/28/2013 | CA2844306A1 Anti-tie2 antibodies and uses thereof |
| 02/28/2013 | CA2844143A1 Fc-free antibodies comprising two fab fragments and methods of use |
| 02/28/2013 | CA2844141A1 Anti-mcsp antibodies |
| 02/28/2013 | CA2837975A1 Bispecific t cell activating antigen binding molecules |
| 02/27/2013 | EP2562188A2 Compositions and methods for diagnosing and treating cancer |
| 02/27/2013 | EP2562187A1 Anti-CD37 antibodies |
| 02/27/2013 | EP2562186A1 Antigen binding proteins that bind PAR-2 |
| 02/27/2013 | EP2562185A1 Antibody against human TSH and canine TSH |
| 02/27/2013 | EP2562178A1 Filler for affinity chromatography |
| 02/27/2013 | EP2560995A1 Assay for identification of lrrk2 inhibitors |
| 02/27/2013 | EP2560994A2 Antibodies to cd122 |
| 02/27/2013 | EP2560993A2 Heterodimeric antibody fc-containing proteins and methods for production thereof |
| 02/27/2013 | EP2560992A2 Binding domains |
| 02/27/2013 | EP2560989A1 Cancer-related glycopeptide epitopes, antibodies and methods of use |
| 02/27/2013 | EP2560691A2 Process for preparing an immunoglobulin composition |
| 02/27/2013 | EP2560684A1 Fibronectin type iii domain-based multimeric scaffolds |
| 02/27/2013 | EP2560683A2 Production of heteromultimeric proteins |
| 02/27/2013 | EP2560682A2 Antibody preparations |
| 02/27/2013 | EP2560681A1 Use of tau to monitor immunotherapy |